Epstein-barr virus infection is common in inflamed gastrointestinal mucosa

Digestive Diseases and Sciences

Volumn 57, Issue 7, 2012, Pages 1887-1898

  Ryan, Julie L ^a   Shen, You Jun ^b   Morgan, Douglas R ^c   Thorne, Leigh B ^c   Kenney, Shannon C ^d   Dominguez, Ricardo L ^e   Gulley, Margaret L ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Sentara Virginia Beach General Hospital   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e Western Regional Hospital   (Honduras)

Author keywords

Colitis; Epstein Barr virus; Gastritis; Gene expression; Inflammation; Viral load

Indexed keywords

CD20 ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; BAMH1 GENE; BZLF1 GENE; CHILD; CROHN DISEASE; EBER1 GENE; EBNA1 GENE; EPSTEIN BARR VIRUS INFECTION; GASTRITIS; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LMP1 GENE; LMP2 GENE; NONHUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS; VIRUS GENOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GASTRITIS; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INTESTINAL MUCOSA; LYMPHOCYTES; POLYMERASE CHAIN REACTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; TRANS-ACTIVATORS; YOUNG ADULT;

EID: 84864285252     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2116-5     Document Type: Article

References (60)

1. Correa P, Piazuelo MB, Camargo MC. The future of gastric cancer prevention. Gastric Cancer. 2004;7:9-16. (Pubitemid 38470689)
2. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virusrelated disease. J Mol Diagn. 2008;10:279-292. (Pubitemid 352022708)
3. Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA. 1994;91: 9131-9135.
4. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol. 1996;27:20-27. (Pubitemid 26015577)
5. Zhang Y, Molot R. Severe gastritis secondary to Epstein-Barr viral infection. Unusual presentation of infectious mononucleosis and associated diffuse lymphoid hyperplasia in gastric mucosa. Arch Pathol Lab Med. 2003;127:478-480. (Pubitemid 36443686)
6. Owens SR, Walls A, Krasinskas AM, Rund CR. Epstein-barr virus gastritis: rare or rarely sampled? A case report. Int J Surg Pathol. 2011;19:196-198.
7. Toll AD, Malik S, Tuluc M. Ulcerative gastritis secondary to Epstein-Barr viral infection. Dig Dis Sci. 2010;55:218-219.
8. Kitayama Y, Honda S, Sugimura H. Epstein-Barr virus-related gastric pseudolymphoma in infectious mononucleosis. Gastroin-test Endosc. 2000;52:290-291. (Pubitemid 30650279)
9. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med. 1999;190:567-576. (Pubitemid 29395384)
10. Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117:4726-4735.
11. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer - a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405-417.
12. Schneider BG, Gulley ML, Eagan P, Bravo JC, Mera R, Geradts J. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. Hum Pathol. 2000;31: 45-50. (Pubitemid 30054386)
13. Arikawa J, Tokunaga M, Tashiro Y, et al. Epstein-Barr virus-positive multiple early gastric cancers and dysplastic lesions: a case report. Pathol Int. 1997;47:730-734. (Pubitemid 27460765)
14. Yanai H, Takada K, Shimizu N, Mizugaki Y, Tada M, Okita K. Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol. 1997;183:293-298. (Pubitemid 27505214)
15. Arikawa J, Tokunaga M, Satoh E, Tanaka S, Land CE. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study. Pathol Int. 1997;47:360-367. (Pubitemid 27274208)
16. Hungermann D, Muller S, Spieker T, Lisner R, Niedobitek G, Herbst H. Low prevalence of latently Epstein-Barr virus-infected cells in chronic gastritis. Microsc Res Tech. 2001;53:409-413. (Pubitemid 32525715)
17. Hirano A, Yanai H, Shimizu N, et al. Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Cancer. 2003;34:87-94.
18. Fukayama M, Chong JM, Uozaki H. Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. Curr Top Microbiol Immunol. 2001;258:91-102. (Pubitemid 32574035)
19. Jing X, Nakamura Y, Nakamura M, et al. Detection of Epstein-Barr virus DNA in gastric carcinoma with lymphoid stroma. Viral Immunol. 1997;10:49-58. (Pubitemid 27168273)
20. Zur Hausen A, van Rees BP, van Beek J et al. Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J Clin Pathol. 2004;57:487-491. (Pubitemid 38621793)
21. Shukla SK, Prasad KN, Tripathi A, et al. Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases. Braz J Infect Dis. 2011;15:583-590.
22. Minoura-Etoh J, Gotoh K, Sato R, et al. Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol. 2006;55:905-911. (Pubitemid 43974697)
23. Kojima Y, Mogaki M, Takagawa R, et al. A case of lymphoep-ithelioma-like carcinoma of the colon with ulcerative colitis. J Gastroenterol. 2007;42:181-185. (Pubitemid 46404224)
24. Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol. 2003;24: 584-588. (Pubitemid 37338526)
25. Vaughan JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epi-topes. Presence in autoimmune disease. J Clin Invest. 1995;95: 1316-1327.
26. Harley JB, Harley IT, Guthridge JM, James JA. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus. 2006;15: 768-777.
27. Lunemann JD, Munz C. Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep. 2007;7:253-258. (Pubitemid 46831520)
28. Swanson-Mungerson M, Longnecker R. Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol. 2007;28:213-218. (Pubitemid 46667241)
29. Ryan JL, Fan H, Glaser SL, Schichman SA, Raab-Traub N, Gulley ML. Epstein-Barr virus quantization by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn. 2004;6:378-385. (Pubitemid 39517407)
30. Ling PD, Vilchez RA, Keitel WA, et al. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003;37:1244-1249. (Pubitemid 37372515)
31. Glaser SL, Gulley ML, Borowitz MJ, et al. Inter- and intra-observer reliability of Epstein-Barr virus detection in Hodgkin lymphoma using histochemical procedures. Leuk Lymphoma. 2004;45:489-497. (Pubitemid 38196031)
32. Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nomura A. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer.1995;60:642- 644.
33. van Beek J, van Zur Hausen A, Klein Kranenbarg E, et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664-670. (Pubitemid 41095069)
34. Oda K, Koda K, Takiguchi N, Nunomura M, Seike K, Miyazaki M. Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes. Gastric Cancer. 2003;6:173-178. (Pubitemid 37221568)
35. Luqmani YA, Linjawi SO, Shousha S. Detection of Epstein-Barr virus in gastrectomy specimens. Oncol Rep. 2001;8:995-999. (Pubitemid 33758157)
36. Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer. 1994;73:2239-2249. (Pubitemid 2080372)
37. Yuen ST, Chung LP, Leung SY, Luk IS, Chan SY, Ho J. In situ detection of Epstein-Barr virus in gastric and colorectal adeno-carcinomas. Am J Surg Pathol. 1994;18:1158-1163. (Pubitemid 24337623)
38. Morgan DR, Dominguez RL, Keku TO, et al. Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol. 2006;4:1103-1111. (Pubitemid 44311643)
39. Greenberg ER, Anderson GL, Morgan DR, et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helico-bacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011;378:507-514.
40. Cho HJ, Kim JY, Yoo J, Lee SS. Gastric carcinoma with lym-phoid stroma: incidence of EBV and Helicobacter pylori infection. Appl Immunohistochem Mol Morphol. 2003;11:149-152. (Pubitemid 36749568)
41. Normark S, Nilsson C, Normark BH, Hornef MW. Persistent infection with Helicobacter pylori and the development of gastric cancer. Adv Cancer Res. 2003;90:63-89. (Pubitemid 37549221)
42. Wong NA, Herbst H, Herrmann K, et al. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas. J Pathol. 2003;201:312-318. (Pubitemid 37264910)
43. Spieker T, Herbst H. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol. 2000;157:51-57. (Pubitemid 30641724)
44. Wakefield AJ, Fox JD, Sawyerr AM, et al. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol. 1992;38:183-190.
45. Gehlert T, Devergne O, Niedobitek G. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. J Med Virol. 2004;73:432-438. (Pubitemid 38685751)
46. Ruther U, Nunnensiek C, Muller HA, Bader H, May U, Jipp P. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). Hepatogastroenterology. 1998;45:691-699. (Pubitemid 28321042)
47. Yanai H, Shimizu N, Nagasaki S, Mitani N, Okita K. Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am J Gastroenterol. 1999;94:1582-1586. (Pubitemid 29260449)
48. Marszalek A, Marciniak R, Szkaradkiewicz A, et al. Inflammatory bowel disease - is there something new in the immunological background? Folia Histochem Cytobiol. 2011;49:357-362.
49. Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci. 2009;54:2456-2462.
50. Sipponen T, Turunen U, Lautenschlager I, Nieminen U, Arola J, Halme L. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease. Scand J Gastroenterol. 2011;46:1324-1333.
51. Baumann MA, Paul CC. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes. Blood. 1992;79:1763-1767.
52. Tosato G, Tanner J, Jones KD, Revel M, Pike SE. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol. 1990;64:3033-3041. (Pubitemid 20171296)
53. Mauser A, Holley-Guthrie E, Zanation A, et al. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol. 2002;76:12543-12552. (Pubitemid 35386940)
54. Israel BF, Kenney SC. Virally targeted therapies for EBV-associated malignancies. Oncogene. 2003;22:5122-5130. (Pubitemid 37059593)
55. Kenney S, Theodore E. Woodward award: development of novel, EBV-targeted therapies for EBV-positive tumors. Trans Am Clin Climatol Assoc. 2006;117:55-74.
56. Foxman EF, Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol. 2011;9:254-264.
57. Young VB. The intestinal microbiota in health and disease. Curr Opin Gastroenterol. 2012;28:63-69.
58. Chai H, Brown RE. Field effect in cancer - an update. Ann Clin Lab Sci. 2009;39:331-337.
59. Meckes DG Jr, Raab-Traub N. Microvesicles and viral infection. J Virol. 2011;85:12844-12854.
60. Pegtel DM, van de Garde MD, Middeldorp JM. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim Biophys Acta. 1809; 2011:715-721.